ROSOL MICHAEL STANLEY (Chief Medical Officer) received a stock award from NAVIDEA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/13/2022ACC: 0001437749-22-022307
Officer· Chief Medical Officer
Since Dec 2018
+41.15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
41.15K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28.15K
Price / share
—
Trade value
—
% of position
193.1%
9/9/2022
14.57K→42.73K
Common Stock
Direct
Shares
+13K
Price / share
—
Trade value
—
% of position
30.4%
9/9/2022
42.73K→55.73K
Total
Net shares
+41.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2022 | A · Award | +28.15K | — | — | 193.1% | 14.57K | 42.73K |
| Common Stock Direct | 9/9/2022 | A · Award | +13K | — | — | 30.4% | 42.73K | 55.73K |
| Total | +41.15K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned11.32K
Total
11.32K indirect11.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 11.32K | Indirect |
| Total | 11.32K | 11.32K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported